Page last updated: 2024-09-03

dioscin and Di Guglielmo Disease

dioscin has been researched along with Di Guglielmo Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huo, X; Liu, K; Liu, Q; Ma, X; Meng, Q; Peng, J; Sun, H; Wang, C; Wang, L	1

Other Studies

1 other study(ies) available for dioscin and Di Guglielmo Disease

Article	Year
Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia K562/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-κB signaling inhibition. Journal of natural products, 2013, May-24, Volume: 76, Issue:5 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Dioscorea; Diosgenin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; I-kappa B Proteins; K562 Cells; Leukemia, Erythroblastic, Acute; Luciferases; NF-kappa B; NF-KappaB Inhibitor alpha; RNA, Messenger; Signal Transduction	2013

Article

Year

Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia K562/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-κB signaling inhibition.

Journal of natural products, 2013, May-24, Volume: 76, Issue:5

Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Dioscorea; Diosgenin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; I-kappa B Proteins; K562 Cells; Leukemia, Erythroblastic, Acute; Luciferases; NF-kappa B; NF-KappaB Inhibitor alpha; RNA, Messenger; Signal Transduction

2013